Managed Care Weekly Digest
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Glioblastoma
Researchers from Duke University detail new studies and findings in the area of glioblastoma
June 15th, 2009
In this recently published article, scientists in the United States conducted a study "To quantify the repeatability of apparent diffusion coefficient (ADC) and fractional anisotropy (FA) in patients with glioblastoma multiforme. IRB approval and informed consent were obtained for this Health Insurance portability and Accountability Act-compliant study." "Sixteen patients with glioblastoma multiforme underwent MR imaging at two time points without interval intervention. ADC and FA maps were registered to the contrast-enhanced and fluid-attenuated inversion recovery (FLAIR) image volumes. Volumes of tumor-related enhancement (TRE) and FLAIR signal abnormality (FSA) were...
Source: Managed Care Weekly Digest (2009-06-15)
|
